Allspring Global Investments Holdings, LLC Apellis Pharmaceuticals, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

A detailed history of Allspring Global Investments Holdings, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 6,522 shares of APLS stock, worth $216,139. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,522

Previous 72,468 91.0%

Holding current value

$216,139

Previous $2.78 Million 93.23%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$28.84 - $41.15 $1.9 Million - $2.71 Million	-65,946 Reduced 91.0%	6,522 $188,000
Q2 2024 Jul 26, 2024	SELL	$38.07 - $59.71 $1.64 Million - $2.57 Million	-42,985 Reduced 37.23%	72,468 $2.78 Million
Q1 2024 Apr 18, 2024	BUY	$55.39 - $72.47 $3.11 Million - $4.07 Million	56,178 Added 94.78%	115,453 $6.79 Million
Q4 2023 Jan 25, 2024	SELL	$37.14 - $64.82 $603,265 - $1.05 Million	-16,243 Reduced 21.51%	59,275 $3.55 Million
Q3 2023 Oct 27, 2023	BUY	$23.65 - $89.22 $1.79 Million - $6.74 Million	75,518 New	75,518 $2.87 Million
Q2 2023 Jul 18, 2023	SELL	$76.68 - $93.31 $172,990 - $210,507	-2,256 Reduced 1.72%	128,655 $11.7 Million
Q1 2023 Apr 13, 2023	BUY	$46.59 - $66.96 $191,857 - $275,741	4,118 Added 3.25%	130,911 $8.63 Million
Q4 2022 Jan 23, 2023	BUY	$43.24 - $61.04 $91,755 - $129,526	2,122 Added 1.7%	126,793 $0
Q3 2022 Oct 26, 2022	BUY	$44.76 - $69.66 $5.34 Million - $8.31 Million	119,363 Added 2248.74%	124,671 $8.52 Million
Q2 2022 Jul 25, 2022	SELL	$35.07 - $59.21 $833,298 - $1.41 Million	-23,761 Reduced 81.74%	5,308 $240,000
Q1 2022 May 02, 2022	BUY	$35.46 - $54.12 $81,593 - $124,530	2,301 Added 8.6%	29,069 $1.48 Million
Q4 2021 Jan 28, 2022	BUY	$30.74 - $49.16 $822,848 - $1.32 Million	26,768 New	26,768 $1.27 Million

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account

Allspring Global Investments Holdings, LLC Apellis Pharmaceuticals, Inc. Transaction History